In vitro evaluation of antibacterial activities and anti-inflammatory effects of bifidobacterium spp. Addressing acne vulgaris

Archives of Pharmacal Research

Volumn 35, Issue 6, 2012, Pages 1065-1071

  Lee, Do Kyung ^a   Kim, Mi Jin ^a   Ham, Ji Wook ^a   An, Hyang Mi ^a   Cha, Min Kyung ^a   Lee, Si Won ^a   Park, Cheol In ^b   Shin, Seon Hee ^c   Lee, Kang Oh ^a   Kim, Kyung Jae ^a   Ha, Nam Joo ^a  

^a Sahmyook University   (South Korea)

^b Daegu Health College   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Anti inflammatory; Antibacterial; Bifidobacteria; Propionibacterium acne; Staphylococcus aureus; TNF

Indexed keywords

CLINDAMYCIN; NITRIC OXIDE; PROBIOTIC AGENT; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ACNE VULGARIS; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; COCULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; IN VITRO STUDY; MACROPHAGE; MEDIATOR RELEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PROPIONIBACTERIUM ACNES; RISK REDUCTION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRASOUND; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;

ACNE VULGARIS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BIFIDOBACTERIUM; CELL LINE; DISK DIFFUSION ANTIMICROBIAL TESTS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; NITRIC OXIDE; PROPIONIBACTERIUM ACNES; SONICATION; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864911778     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0614-9     Document Type: Article

References (38)

1. Armold, H. L., Odom, R. B., and James, W. D., Andrews' Diseases of the skin, Clinical Dermatology, 8th ed. WB Saunders Co., Philadelphia, USA, (1990).
2. Bielecka, M., Biedrzycka, E., Biedrzycka, E., Smoragiewicz, W., and Smieszek, M., Interaction of Bifidobacterium and Salmonella during associated growth. Int. J. Food Microbiol., 45, 151-155 (1998). (Pubitemid 29049107)
3. Cheikhyoussef, A., Pogori, N., Chen, W., and Zhang, H., Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Int. J. Food Microbiol., 125, 215-222 (2008).
4. Chomnawang, M. T., Surassmo, S., Nukoolkarn, V. S., and Gritsanapan, W., Antimicrobial effects of Thai medicinal plants against acne-inducing bacteria. J. Ethnopharmacol., 101, 330-333 (2005). (Pubitemid 41265642)
5. Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing; seventh informational supplement 27, Suit, USA, pp. 98- 114, (2007).
6. Coates, P., Vyakrnam, S., Eady, E. A., Jones, C. E., Cove, J. H., and Cunliffe, W. J., Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br. J. Dermatol., 146, 840-848 (2002). (Pubitemid 34539195)
7. De Vuyst, L., Callewaert, R., and Pot, B., Characterization of the antagonistic activity of Lactobacillus amylovorus DCE 471 and large scale isolation of its bacteriocin amylovorin L471. Syst. Appl. Microbiol., 19, 9-20 (1996). (Pubitemid 26138148)
8. Docherty, J. J., McEwen, H. A., Sweet, T. J., Bailey, E., and Booth, T. D., Resveratrol inhibition of Propionibacterium acnes. J. Antimicrob. Chemother., 59, 1182-1184 (2007). (Pubitemid 47078720)
9. Eady, E. A., Bacterial resistance in acne. Dermatology, 196, 59-66 (1998). (Pubitemid 28116041)
10. Fuller, R., Probiotics in man and animals. J. Appl. Bacteriol., 66, 365-378 (1989).
11. Garro, M. S., de Valdez, G. F., and de Giori, G. S., Temperature effect on the biological activity of Bifidobacterium longum CRL849 and Lactobacillus fermentum CRL251 in pure and mixed cultures grown in soymilk. Food Microbiol., 21, 511-518 (2004). (Pubitemid 38587805)
12. Hammes, W. P. and Tichaczek, P. S., The potential of lactic acid bacteria for the production of safe and wholesome food. Z. Lebensm. Unters. Forsch., 198, 193-201 (1994).
13. Han, S., Cho, K., Lee, C.-K., Song, Y., Park, S. H., Ha, N.-J., and Kim, K., Enhancement of antigen presentation capability of dendritic cells and activation of macrophages by the components of Bifidobacterium pseudocatenulatum SPM1204. J. Appl. Pharmacol., 13, 174-180 (2005).
14. Han, S. M., Lee, K. G., Yeo, J. H., Kim, W. T., and Park, K. K., Antimicrobial Property of honeybee (Apis mellifera L.) venom against Propionibacterium acnes and Aerobic Skin Flora. Kor. J. Pharmacogn., 40, 173-177 (2009).
15. Hassanzadeh, P., Bahmani, M., and Mehrabani, D., Bacterial resistance to antibiotics in acne vulgaris: an in vitro study. Indian J. Dermatol., 53, 122-124 (2008).
16. Hatcher, G. E. and Lambrecht, R. S., Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J. Dairy Sci., 76, 2485-2492 (1993).
17. Henriksson, A. and Conway, P. L., Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice. J. Appl. Microbiol., 90, 223-228 (2001). (Pubitemid 32158742)
18. Kim, S. S., Kim, J. Y., Lee, N. H., and Hyun, C. G., Antibacterial and anti-inflammatory effects of Jeju medicinal plants against acne-inducing bacteria. J. Gen. Appl. Microbiol., 54, 101-106 (2008). (Pubitemid 351850737)
19. Lee, D. K., Jang, S., Kim, M. J., Kim, J. H., Chung, M. J., Kim, K. J., and Ha, N. J., Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer, 8, 310 (2008a).
20. Lee, D. K., Kang, B. Y., Chung, M. J., Lee, K. O., Kim, K., and Ha, N. J., Genomic fingerprinting patterns of Bifidobacteria isolated from healthy Koreans using ERIC-, TAP-, and BOX-PCR. J. Environ. Toxicol., 23, 1-9 (2008b).
21. Lee, D. K., Jang, S., Baek, E. H., Kim, M. J., Lee, K. S., Shin, H. S., Chung, M. J., Kim, J. E., Lee, K. O., and Ha, N. J., Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis., 8, 21 (2009).
22. Leyden, J. J., McGinley, K. J., Cavalieri, S., Webster, G. F., Mills, O. H., and Kligman, A. M., Propionibacterium acnes resistance to antibiotics in acne patients. J. Am. Acad. Dermatol., 8, 41-45 (1983). (Pubitemid 13221137)
23. Liu, P. F., Nakatsuji, T., Zhu, W., Gallo, R. L., and Huang, C. M., Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris. Vaccine, 29, 3230-3238 (2011).
24. Magee, J. S. and Schutze, G. E., Bacterial infections of the skin. Semin. Pediatr. Infect. Dis., 8, 215-219 (1997). (Pubitemid 27469131)
25. Nagy, I., Pivarcsi, A., Kis, K., Koreck, A., Bodai, L., McDowell, A., Seltmann, H., Patrick, S., Zouboulis, C. C., and Kemeny, L., Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect., 8, 2195-2205 (2006). (Pubitemid 44335873)
26. Oprica, C., Emtestam, L., Lapins, J., Borglund, E., Nyberg, F., Stenlund, K., Lundeberg, L., Sillerstrom, E., and Nord, C. E., Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe, 10, 155-164 (2004). (Pubitemid 38789116)
27. Park, S. H., Kim, Y. A., Lee, D. K., Lee, S., Chung, M. J., Kang, B. Y., Kim, K., and Ha, N. J., Antibacterial activity and macrophage activation of lactic acid bacteria. J. Environ. Toxicol., 22, 287-297 (2007).
28. Park, S. Y., Ji, G. E., Ko, Y. T., Jung, H. K., Ustunol, Z., and Pestka, J. J., Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol., 46, 231-241 (1999). (Pubitemid 29104877)
29. Sekine, K., Kasashima, T., and Hashimoto, Y., Comparison of the TNF-α levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora, 13, 79-89 (1994).
30. Servin, A. L., Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev., 28, 405-440 (2004). (Pubitemid 39209464)
31. Sgorbati, B., Biavati, B., and Palenzona, D., The genus šeBifidobacteriumšf. In Wood, B. J. B. and Holzapfel, W. H. (Eds.), The Lactic Acid Bacteria. The Genera of Lactic Acid Bacteria, Blackie Academic, London, 2, pp. 279-306, (1995).
32. Tissier, H., Recherchers sur la flora intestinale normale et pathologique dunourisson. Ph.D. Thesis, University of Paris, Paris, France, pp. 1-253, (1900).
33. Webster, G. F. and Graber, E. M., Antibiotic treatment of acne vulgaris. Semin. Cutan. Med. Surg., 27, 183-187 (2008).
34. Williams, H. C., Dellavalle, R. P., and Garner, S., Acne vulgaris. Lancet, 379, 361-372 (2012).
35. Yasui, H. and Ohwaki, M., Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J. Dairy Sci., 74, 1187-1195 (1991).
36. Youn, S. W., The role of facial sebum secretion in acne pathogenesis: facts and controversies. Clin. Dematol., 28, 8-11 (2010).
37. Yusof, R. M., Haque, F., Ismaill, M., and Hassan, Z., Isolation of Bifidobacteria infantis and its antagonistic activity against ETEC 0157 and Salmonella typhimurium S-285 in weaning foods. Asia Pac. J. Clin. Nutr., 9, 130-135 (2000).
38. Zommara, M., Tachibana, N., Sakono, M., Suzuki, Y., Oda, T., Hashiba, H., and Imaizumi, K., Whey from cultured skim milk decreases serum cholesterol and increases antioxidant enzymes in liver and red blood cells in rats. Nutr. Res., 16, 293-302 (1996). (Pubitemid 26066187)